Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

Metatag Title
World Top Biotechnology Companies in 2026
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.
  1. Medpace Holdings

    World Rank (Aug-2026)
    1,482
    Market Cap (Aug-2026)
    16.147 Billion USD
    World Rank (Jan-05-2024)
    1,782
    Market Cap (Jan-05-2024)
    9.093 Billion USD
    World Rank (Jul-30-2023)
    2,061
    Market Cap (Jul-30-2023)
    7.771 Billion USD
    World Rank (Dec-25-2022)
    2,151
    Market Cap (Dec-25-2022)
    6.616 Billion USD
    World Rank (Jan-07-2022)
    2,575
    Market Cap (Jan-07-2022)
    6.76 Billion USD
    Annual Revenue in USD
    2,530 Million USD
    Annual Operating Income in USD
    535 Million USD
    Annual Net Income in USD
    451 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Medpace Holdings clinical research, therapeutic and specialty areas are autoimmune diseases, cardiovascular, endocrine and metabolic, hematology and oncology, infectious diseases and vaccines, nephrology, neuroscience, pediatrics, rare disease and orphan indications and advanced therapies. The headquarters is in USA.

  2. Jazz Pharmaceuticals

    World Rank (Aug-2026)
    1,491
    Market Cap (Aug-2026)
    15.901 Billion USD
    World Rank (Jan-05-2024)
    2,029
    Market Cap (Jan-05-2024)
    7.892 Billion USD
    World Rank (Jul-30-2023)
    1,938
    Market Cap (Jul-30-2023)
    8.393 Billion USD
    World Rank (Dec-25-2022)
    1,546
    Market Cap (Dec-25-2022)
    9.898 Billion USD
    World Rank (Jan-07-2022)
    2,179
    Market Cap (Jan-07-2022)
    8.26 Billion USD
    Annual Revenue in USD
    3,659 Million USD
    Annual Operating Income in USD
    512 Million USD
    Annual Net Income in USD
    -224 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Bio Pharmaceutical company with headquarters is in Dublin, Ireland.
  3. Ipsen

    World Rank (Aug-2026)
    1,503
    Market Cap (Aug-2026)
    15.766 Billion USD
    World Rank (Jan-05-2024)
    1,670
    Market Cap (Jan-05-2024)
    9.900 Billion USD
    World Rank (Jul-30-2023)
    1,617
    Market Cap (Jul-30-2023)
    10.484 Billion USD
    World Rank (Dec-25-2022)
    1,726
    Market Cap (Dec-25-2022)
    8.637 Billion USD
    World Rank (Jan-07-2022)
    2,325
    Market Cap (Jan-07-2022)
    7.70 Billion USD
    Annual Revenue in USD
    3,480 Million USD
    Annual Operating Income in USD
    960 Million USD
    Annual Net Income in USD
    714 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Ipsen is a global biopharmaceutical group dedicated to improving lives and health outcomes through innovative medicines in Oncology. Headquarters is in France.

  4. Serum Institute of India

    World Rank (Aug-2026)
    1,523
    World Rank (Jan-05-2024)
    1,523
    World Rank (Jul-30-2023)
    1,523
    World Rank (Dec-25-2022)
    1,523
    World Rank (Jan-07-2022)
    1,523
    Headquarters Country
    Company Profile

    Serum Institute of India Pvt. Ltd. is now the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute.

  5. BridgeBio Pharma

    World Rank (Aug-2026)
    1,527
    Market Cap (Aug-2026)
    15.612 Billion USD
    World Rank (Jan-05-2024)
    2,350
    Market Cap (Jan-05-2024)
    6.583 Billion USD
    World Rank (Jul-30-2023)
    2,721
    Market Cap (Jul-30-2023)
    5.524 Billion USD
    World Rank (Dec-25-2022)
    7,610
    Market Cap (Dec-25-2022)
    1.178 Billion USD
    World Rank (Jan-07-2022)
    5,962
    Market Cap (Jan-07-2022)
    2.16 Billion USD
    Annual Revenue in USD
    502 Million USD
    Annual Operating Income in USD
    -523 Million USD
    Annual Net Income in USD
    -733 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    BridgeBio Pharma is a biotechnology company that develop and deliver breakthrough medicines for genetic diseases to patients as quickly and safely as possible. The headquarters is in USA.
  6. Neurocrine Biosciences

    World Rank (Aug-2026)
    1,534
    Market Cap (Aug-2026)
    15.524 Billion USD
    World Rank (Jan-05-2024)
    1,326
    Market Cap (Jan-05-2024)
    13.124 Billion USD
    World Rank (Jul-30-2023)
    1,672
    Market Cap (Jul-30-2023)
    10.026 Billion USD
    World Rank (Dec-25-2022)
    1,362
    Market Cap (Dec-25-2022)
    11.566 Billion USD
    World Rank (Jan-07-2022)
    2,475
    Market Cap (Jan-07-2022)
    7.15 Billion USD
    Annual Revenue in USD
    2,861 Million USD
    Annual Operating Income in USD
    619 Million USD
    Annual Net Income in USD
    479 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Neurocrine Biosciences is a Neuroscience Focused and Biopharmaceutical company. It is discovering and developing life-changing treatments for people with serious, challenging, under addressed neurological, endocrine and psychiatric disorders. The headquarters is in USA.

  7. Ascendis Pharma A/S

    World Rank (Aug-2026)
    1,550
    Market Cap (Aug-2026)
    15.401 Billion USD
    World Rank (Jan-05-2024)
    2,135
    Market Cap (Jan-05-2024)
    7.414 Billion USD
    World Rank (Jul-30-2023)
    2,847
    Market Cap (Jul-30-2023)
    5.234 Billion USD
    World Rank (Dec-25-2022)
    2,096
    Market Cap (Dec-25-2022)
    6.791 Billion USD
    World Rank (Jan-07-2022)
    2,604
    Market Cap (Jan-07-2022)
    6.65 Billion USD
    Annual Revenue in USD
    56 Million USD
    Annual Operating Income in USD
    -619 Million USD
    Annual Net Income in USD
    -643 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Bio-pharmaceutical company with headquarters is in Denmark.
  8. Prometheus Biosciences Inc.

    World Rank (Aug-2026)
    1,740
    World Rank (Jan-05-2024)
    1,740
    World Rank (Jul-30-2023)
    1,740
    Market Cap (Jul-30-2023)
    9.560 Billion USD
    World Rank (Dec-25-2022)
    2,691
    Market Cap (Dec-25-2022)
    5.073 Billion USD
    World Rank (Jan-07-2022)
    7,819
    Market Cap (Jan-07-2022)
    1.38 Billion USD
    Annual Revenue in USD
    7 Million USD
    Annual Operating Income in USD
    -146 Million USD
    Annual Net Income in USD
    -142 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    Company Profile

    Prometheus Biosciences, Inc. is a biotechnology company focused on the precision approach is designed to transform the treatment of immune-mediated diseases starting with inflammatory bowel disease (IBD). The company annual revenue is 3 million USD and annual net loss of 90 million USD for year ending December 2021. The headquarters is in USA.

    Merck acquired Prometheus Biosciences Inc. for 11 billion USD in the year 2022.

  9. Charles River Laboratories International

    World Rank (Aug-2026)
    1,745
    Market Cap (Aug-2026)
    13.369 Billion USD
    World Rank (Jan-05-2024)
    1,471
    Market Cap (Jan-05-2024)
    11.492 Billion USD
    World Rank (Jul-30-2023)
    1,589
    Market Cap (Jul-30-2023)
    10.773 Billion USD
    World Rank (Dec-25-2022)
    1,409
    Market Cap (Dec-25-2022)
    11.117 Billion USD
    World Rank (Jan-07-2022)
    1,223
    Market Cap (Jan-07-2022)
    16.59 Billion USD
    Annual Revenue in USD
    4,015 Million USD
    Annual Operating Income in USD
    25 Million USD
    Annual Net Income in USD
    -144 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    Charles River Laboratories is a Healthcare and pharmaceutical company. The company products and services are Research animals models, genetically engineered model and services, animal health, surveillance, surgery and precondition service, generic testing services and Insourcing solutions. The headquarters is in USA.

    The company currently operated 110 facilities in 20 countries.

    Facts About Company

    Charles River Laboratories annual revenue generated for period ending Dec-2022 was 3,976 million USD.

    Charles River Laboratories annual net income generated for period ending Dec-2022 was 486 million USD.

    Charles River Laboratories annual revenue generated for period ending Dec-2021 was 3,540 million USD.

    Charles River Laboratories annual net income generated for period ending Dec-2021 was 391 million USD.

  10. BioMarin Pharmaceutical

    World Rank (Aug-2026)
    1,775
    Market Cap (Aug-2026)
    13.039 Billion USD
    World Rank (Jan-05-2024)
    985
    Market Cap (Jan-05-2024)
    18.409 Billion USD
    World Rank (Jul-30-2023)
    1,112
    Market Cap (Jul-30-2023)
    16.444 Billion USD
    World Rank (Dec-25-2022)
    863
    Market Cap (Dec-25-2022)
    19.391 Billion USD
    World Rank (Jan-07-2022)
    1,308
    Market Cap (Jan-07-2022)
    15.47 Billion USD
    Annual Revenue in USD
    3,221 Million USD
    Annual Operating Income in USD
    409 Million USD
    Annual Net Income in USD
    349 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Biomarin Pharmaceutical is Pharmaceutical and Biotechnology Company with headquarters is in California, USA.

    It develops innovate therapies and life-threatening rare diseases and medical conditions.It consists of seven commercial products for the treatment of various diseases.

    As on 2022, Biomarin Pharmaceutical has 3,082 employees.

    Biomarin Pharmaceutical annual revenue generated for period ending Dec-2022 was 2,096 million USD.

Share

Ads